gouty arthritis?hyperuricemia
Conditions
Interventions
Treatment group:Basic therapy + Kang-acid tea
Sponsors
Yunnan Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for gout of the American College of Rheumatology; 2. Meet the criteria for intermittent staging of gouty arthritis; 3. Blood uric acid value: male =420umol/L, female =360umol/L; 4. Routine findings of liver and kidney function and hematuria were normal; 5. Age between 18 and 70 years old (including 18 and 70 years old), both male and female; 6. Volunteer to participate in this study, agree to enter clinical study, and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Secondary gout, joint lesions caused by rheumatoid arthritis, suppurative arthritis, traumatic arthritis, silver shag arthritis, pseudogout, lupus erythematosus and other diseases. Chemotherapy, radiotherapy, chronic lead poisoning, acute obstructive nephropathy and other joint lesions. 2. Patients with late deformities, disabilities, loss of labor force, and cardiovascular and cerebrovascular diseases induced by pain. 3. Severe heart, brain, liver, kidney and other complications or other serious primary diseases, such as tumor or AIDS. 4. Blood Cr, ALT, AST and BUN exceed 1.5 times of the normal value. 5. Participants are participating in other drug clinical trials, or the drug clinical trial group is less than 1 week; 6. Patients who fail to complete drug treatment as prescribed by the doctor, cannot judge the efficacy, have poor compliance, or have incomplete data; 7. Allergic constitution (known allergic to the components of this medicine); 8. Pregnant or lactating women or women who intend to become pregnant; 9. History of neuropsychiatric disorders (epilepsy, depression, etc.); 10. Suspected or existing history of alcohol or drug abuse, or other medical conditions that reduce or complicate enrollment, such as frequent changes in the work environment, may cause loss of follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| erythrocyte sedimentation rate, ESR;C-reactive protein, CRP;blood uric acid, BUA;urine uric acid, UUA; | — |
Secondary
| Measure | Time frame |
|---|---|
| Routine blood testing;Liver function test; | — |
Countries
China
Contacts
Public ContactChen Yanlin
Yunnan Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of
Outcome results
None listed